Published in Eur J Clin Pharmacol on August 14, 1975
Variations in drug free fraction during alcohol withdrawal. Br J Clin Pharmacol (1983) 1.28
Alteration of drug-protein binding in renal disease. Clin Pharmacokinet (1984) 0.99
Diurnal variations in plasma diazepam concentrations associated with reciprocal changes in free fraction. Br J Clin Pharmacol (1980) 0.98
The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin. Clin Pharmacokinet (1984) 0.91
Pethidine binding in whole blood: methodology and clinical significance. Br J Clin Pharmacol (1984) 0.75
Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy. PLoS One (2014) 0.75
Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus. J Clin Med (2016) 0.75
Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med (1978) 2.68
Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med (1971) 1.76
Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. Eur J Clin Pharmacol (1971) 1.72
Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding. Eur J Clin Pharmacol (1974) 1.44
Occupational fluoride exposure and plasma fluoride levels in man. Int Arch Occup Environ Health (1986) 1.27
Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors. Biochem Pharmacol (1976) 1.12
Kinetics of morphine in patients with renal failure. Eur J Clin Pharmacol (1987) 1.04
Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid. Clin Pharmacol Ther (1976) 0.98
Pharmacokinetic and metabolic studies of high-dose busulphan in adults. Eur J Clin Pharmacol (1989) 0.98
Oxazepam disposition in uremic patients. Acta Pharmacol Toxicol (Copenh) (1977) 0.96
Pentazocine binding to blood cells and plasma proteins. Clin Pharmacol Ther (1974) 0.94
Protein binding of diazepam and digitoxin in uremic and normal serum. Biochem Pharmacol (1979) 0.94
Renal clearance of fluoride in a steady state condition in man: influence of urinary flow and pH changes by diet. Acta Pharmacol Toxicol (Copenh) (1982) 0.93
Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors. Pharmacol Toxicol (1990) 0.93
Serum concentration and phototoxic effect of methoxsalen in patients with psoriasis. Clin Pharmacol Ther (1979) 0.90
Kinetics of morphine in patients with renal failure. Lancet (1985) 0.87
The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. Eur J Clin Pharmacol (1980) 0.87
Drug binding to plasma proteins during human pregnancy and in the perinatal period. Studies on cloxacillin and alprenolol. Dev Pharmacol Ther (1983) 0.87
Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal. Eur J Clin Pharmacol (1989) 0.85
Pharmacokinetics of ampicillin and its prodrugs bacampicillin and pivampicillin in man. J Pharmacokinet Biopharm (1979) 0.85
Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration. J Pharm Sci (1974) 0.85
Abnormal pharmacokinetics of phenytoin in a patient with uraemia. Lancet (1970) 0.85
Busulfan kinetics. Clin Pharmacol Ther (1983) 0.84
Plasma protein binding of propranolol in disease states [proceedings]. Br J Clin Pharmacol (1977) 0.84
Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers. Acta Neurol Scand (2012) 0.83
Absorption of fluoride from fluoride dentifrices. Caries Res (1980) 0.83
Care of pressure sores: a controlled study of the use of a hydrocolloid dressing compared with wet saline gauze compresses. Acta Derm Venereol Suppl (Stockh) (1989) 0.83
Influence of milk products on fluoride bioavailability in man. Eur J Clin Pharmacol (1979) 0.83
Glucuronidation of morphine in human kidney microsomes. Pharmacol Toxicol (1988) 0.83
Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations. Psychopharmacology (Berl) (1982) 0.82
Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women. Clin Pharmacokinet (1987) 0.82
Bioavailability and first-pass metabolism of oral pentazocine in man. Clin Pharmacol Ther (1977) 0.82
Degradation of chlorambucil in aqueous solution--influences of human albumin binding. J Pharm Pharmacol (1981) 0.81
Comparative disposition of pethidine and norpethidine in old and young patients. Eur J Clin Pharmacol (1982) 0.81
Acute cardiac failure during treatment with digitoxin--an interaction with rifampicin. Br J Clin Pharmacol (1980) 0.80
Effect of food on kinetics of 8-methoxsalen. Clin Pharmacol Ther (1979) 0.80
Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man. J Pharm Pharmacol (1974) 0.80
Pethidine binding to blood cells and plasma proteins in old and young subjects. Eur J Clin Pharmacol (1982) 0.80
A controlled study of low and high volume anesthetic jelly as a lubricant and pain reliever during cystoscopy. J Urol (1991) 0.80
Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure. Clin Pharmacol Ther (1979) 0.79
Fluoride pharmacokinetics during acid-base balance changes in man. Eur J Clin Pharmacol (1980) 0.78
The relationship between plasma fluoride, urinary excretion rate and urine fluoride concentration in man. J Occup Med (1983) 0.78
Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Growth Regul (1996) 0.78
Drug distribution in whole blood of mothers and their newborn infants: studies of cloxacillin and flucloxacillin. Eur J Clin Pharmacol (1982) 0.78
Timolol and hydrochlorothiazide-amiloride in primary hypertension. Clin Pharmacol Ther (1980) 0.78
Calcitonin gene-related peptide attenuates experimental ischemic renal failure in a rat model of reversible renal ischemic insult. Ren Fail (1994) 0.77
Fluoride bioavailability after intravenous and oral administration: importance of renal clearance and urine flow. Clin Pharmacol Ther (1978) 0.77
Single-dose kinetics and bioavailability of pentazocine. Acta Anaesthesiol Scand Suppl (1982) 0.77
Renal and hemodynamic effects of diltiazem after elective major vascular surgery--a potential renoprotective agent? Ren Fail (1995) 0.77
Pharmacokinetics of free and total flucloxacillin in newborn infants. Eur J Clin Pharmacol (1987) 0.77
Effects of human atrial natriuretic peptide in patients after coronary artery bypass surgery. J Cardiothorac Vasc Anesth (1996) 0.76
Renal effects of human atrial natriuretic peptide in patients after major vascular surgery. Acta Anaesthesiol Scand (1994) 0.75
A hemodialysis patient with heart failure and severe overhydration but near-normal plasma levels of ANP. Nephron (1991) 0.75
Urea, creatinine, uric acid, and phosphate spaces and their relationship to total body water during chronic hemodialysis. ASAIO Trans (1989) 0.75
Absorption and elimination kinetics of 32P malathion in the hen. Acta Pharmacol Toxicol (Copenh) (1977) 0.75
Comparison of renal excretion of pethidine (meperidine) and its metabolites in old and young patients. Eur J Clin Pharmacol (1985) 0.75
Therapeutic abortion by means of intrauterine instillation of hypertonic saline. The occurrence of hemolysis following intravascular injection. Int J Gynaecol Obstet (1974) 0.75
Ischemic colitis of the cecum after renal transplantation masquerading as malignant disease. Dig Dis Sci (1991) 0.75
Pharmacokinetis of alpha- and beta-isomers of racemic endosulfan following intravenous administration in rabbits. Drug Metab Dispos (1979) 0.75
A comparison between microcrystalline and conventional phenytoin preparations: relative bioavailability and steady-state plasma concentrations. J Neurol (1980) 0.75
Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentography. J Pharm Pharmacol (1974) 0.75
Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentration. Eur J Clin Pharmacol (1977) 0.75
Immunoreactive endogenous digoxin-like substances: plasma levels are dependent on the hypothalamic-pituitary-adrenal axis for release and on kidney function for elimination. J Cardiovasc Pharmacol (1993) 0.75
Proceedings: Pharmacokinetics of pentobarbital in humans with special reference to blood cell and plasma protein binding. Acta Pharm Suec (1974) 0.75
Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failure. Eur J Clin Pharmacol (1976) 0.75
Calcium channel blockade and renal function. Acta Pharmacol Toxicol (Copenh) (1986) 0.75
Renal excretion of fluoride during water diuresis and induced urinary pH-changes in man. Toxicol Lett (1983) 0.75
Non-protein nitrogen-containing compounds on the skin of patients with pruritic uremia. Scand J Urol Nephrol (1971) 0.75
The pharmacokinetic profile of oxazepam. Acta Psychiatr Scand Suppl (1978) 0.75
Distribution of ampicillin in human whole blood. J Pharm Pharmacol (1978) 0.75
[Raynaud's phenomenon after treatment with beta-blocking agents]. Lakartidningen (1978) 0.75
Hypertension profiling by total body water (TBW) determinations in patients on chronic hemodialysis. Int J Artif Organs (1991) 0.75
Protein binding of ampicillin. Path analysis of a twin material. Hereditas (1978) 0.75
Pharmacokinetics and distribution of flucloxacillin in pacemaker patients. Eur J Clin Pharmacol (1985) 0.75
[Acute theophylline poisoning treated with combined hemoperfusion and hemodialysis]. Lakartidningen (1982) 0.75
Appearance of pethidine and norpethidine in cerebrospinal fluid of man following intramuscular injection of pethidine. Acta Anaesthesiol Scand (1983) 0.75